Eledon Pharmaceuticals, Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
Eledon Pharmaceuticals, Inc. (ELDN) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$45.78 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-19
- Eledon Pharmaceuticals, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$45.78M.
- Eledon Pharmaceuticals, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$35.95M.
- Eledon Pharmaceuticals, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$116.74M.
- Eledon Pharmaceuticals, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$88.16M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$45.78M 10-K · filed 2026-03-19 | |
| 2024-12-31 | -$35.95M 10-K · filed 2026-03-19 | |
| 2023-12-31 | -$116.74M 10-K/A · filed 2025-08-14 | -$40.52M 10-K · filed 2024-03-28 |
| 2022-12-31 | -$88.16M 10-K/A · filed 2024-08-19 | |
| 2021-12-31 | -$37.05M 10-K · filed 2023-03-30 | |
| 2020-12-31 | -$23.41M 10-K · filed 2022-03-24 | |
| 2019-12-31 | -$16.17M 10-K · filed 2021-03-31 | |
| 2018-12-31 | -$14.18M 10-K · filed 2020-03-17 | |
| 2017-12-31 | -$12.47M 10-K · filed 2019-03-28 | |
| 2016-12-31 | -$2.87M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |